Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H23N3O5 |
Molecular Weight | 421.4458 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
InChI
InChIKey=UCFGDBYHRUNTLO-QHCPKHFHSA-N
InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1
Molecular Formula | C23H23N3O5 |
Molecular Weight | 421.4458 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:30:08 UTC 2023
by
admin
on
Fri Dec 15 15:30:08 UTC 2023
|
Record UNII |
7M7YKX2N15
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QL01XX17
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
POTACTASOL (AUTHORISED: SMALL CELL LUNG CARCINOMA, UTERINE CERVICAL NEOPLASMS)
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
FDA ORPHAN DRUG |
694519
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
HYCAMTIN (AUTHORIZED: OVARIAN NEOPLASMS, SMALL CELL LUNG CARCINOMA, UTERINE CERVICAL NEOPLASMS)
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EVOTOPIN (WITHDRAWN: OVARIAN NEOPLASMS
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
LIVERTOX |
NBK548037
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TOPOTECAN HOSPIRA (AUTHORISED: SMALL CELL LUNG CARCINOMA)
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TOPOTECAN ACTAVIS (AUTHORISED: SMALL CELL LUNG CARCINOMA, UTERINE NEOPLASMS )
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
NDF-RT |
N0000000176
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
TOPOTECAN TEVA (AUTHORIZED: OVARIAN NEOPLASMS, SMALL CELL LUNG CARCINOMA, UTERINE CERVICAL NEOPLASMS)
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
NDF-RT |
N0000175609
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
WHO-ATC |
L01XX17
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
||
|
NCI_THESAURUS |
C2843
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2707
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
7M7YKX2N15
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
63632
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
6783
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
C1413
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
8213
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
Topotecan
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
m10977
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB01030
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
641007
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
7101
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
SUB11191MIG
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
609699
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
CHEMBL84
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
Topotecan
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
60700
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
57308
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000089213
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
D019772
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
123948-87-8
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
7M7YKX2N15
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY | |||
|
DTXSID3042685
Created by
admin on Fri Dec 15 15:30:08 UTC 2023 , Edited by admin on Fri Dec 15 15:30:08 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> SUBSTRATE |
Km
|
||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
TRANSPORTER -> SUBSTRATE |
Vmax
|
||
|
TRANSPORTER -> SUBSTRATE |
Vmax
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE LESS ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE -> PARENT |
Topotecan-O-glucuronide and N-desmethyl topotecan-O-glucuronide, were less than 2% of the administered dose.
URINE
|
||
|
METABOLITE -> PARENT |
FECAL; PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|